No Observations, All Approval—Zydus’ Oncology Plant Passes USFDA Test

Unknown Apr 02, 2026 750 Views

Zydus Lifesciences Ltd has successfully concluded a remote regulatory assessment by the USFDA at its Matodabased oncology injectable manufacturing facility. The inspection ended with no observations, and the site has been recommended for approval, marking a significant compliance achievement for...